Over a 15-year period, prescriptions for analgesics and sedatives to manage HICP decreased while prescriptions for gabapentinoids increased.
The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...